Lifting the Burdens of Idiopathic Hypersomnia

Target Audience

The educational design of this activity addresses the needs of sleep medicine, pulmonology, neurology, and psychiatry specialist physicians (MDs/DOs), nurse practitioners (NPs), and physician associates (PAs) involved in the treatment of patients with idiopathic hypersomnia.

Program Overview

Idiopathic hypersomnia is a chronic, potentially lifelong central disorder of hypersomnolence which has profound disease burdens and health consequences for patients. Furthermore, diagnosis and management have been identified among clinicians as a great challenge due to its nonspecific symptoms and poorly understood pathophysiology.  Lifting the Burdens of Idiopathic Hypersomnia: Accelerating Diagnosis and Individualizing Management is a multimedia training program consisting of 4 circuits that will boost your endurance and strengthen your expertise within the diagnosis and evolving management strategies of IH.

Educational Objectives 

After completing this activity, the participant should be better able to:

• Describe the epidemiology and consequences of idiopathic hypersomnia, including cardiovascular burdens
• Identify patients with idiopathic hypersomnia based on symptoms, sleep evaluations, and testing to rule out other disorders
• Discuss the clinical profiles, published evidence, and prescribing considerations for pharmacotherapy in the treatment of idiopathic hypersomnia
• Construct multimodal treatment regimens for patients with idiopathic hypersomnia based on disease presentation, comorbidities, therapeutic responses, and shared decision-making

Physician Accreditation Statement

Integritas Communications is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physician Credit Designation

Integritas designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Global Education Group is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

This educational activity for 1.0 contact hour including 0.0 pharmacotherapeutic contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Integritas Contact Information

For information about the accreditation (ACCME credit) of this program, please contact Integritas at info@exchangecme.com.

Global Contact Information

For information about the accreditation (ANCC credit) of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

Instructions to Receive Credit

In order to receive credit for this activity, the participant must:

1. Read the educational objectives, accreditation information, and faculty disclosures at the beginning of this activity.
2. Complete the Preactivity Questions.
3. Review the activity content.
4. Achieve a grade of at least 70% on the Postactivity Test and complete the Evaluation.

Fee Information & Refund/Cancellation Policy

There is no fee for this educational activity.

Disclosures of Relevant Financial Relationships

Integritas Communications and Global Education Group (Global) adhere to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global.  All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.  

All relevant financial relationships have been mitigated. 

The faculty have the following relevant financial relationships with ineligible companies:

Richard K. Bogan, MD, FCCP, FAASM: Consulting Fees: Avadel Pharmaceuticals plc, Axsome Therapeutics, Inc., Harmony Biosciences, Idorsia Pharmaceuticals Ltd, Jazz Pharmaceuticals, Inc.

Karl Doghramji, MD, FAASM, DFAPA: Consulting Fees: Axsome Therapeutics, Inc., Biogen Inc., Harmony Biosciences, Idorsia Pharmaceuticals Ltd, Janssen Global Services, LLC, Jazz Pharmaceuticals, Inc., Purdue Pharma L.P.; Contracted Research: Inspire Medical Systems, Inc,, Respicardia, Inc., Sommetrics, Inc.; Ownership Interest: Merck & Co., Inc.

The planners and managers at Integritas Communications and Global Education Group have no relevant financial relationships to disclose. 

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Integritas Communications do not recommend the use of any agent outside of the labeled indications.  

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.